DermTech Inc
NASDAQ:DMTK
Balance Sheet
Balance Sheet Decomposition
DermTech Inc
Current Assets | 61.8m |
Cash & Short-Term Investments | 55.9m |
Receivables | 2.6m |
Other Current Assets | 3.3m |
Non-Current Assets | 60.2m |
PP&E | 56.7m |
Other Non-Current Assets | 3.5m |
Current Liabilities | 13.4m |
Accounts Payable | 1.5m |
Accrued Liabilities | 11.8m |
Other Current Liabilities | 213k |
Non-Current Liabilities | 51.3m |
Long-Term Debt | 38k |
Other Non-Current Liabilities | 51.3m |
Balance Sheet
DermTech Inc
Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|
Assets | ||||||
Cash & Cash Equivalents |
15
|
24
|
177
|
78
|
37
|
|
Cash Equivalents |
15
|
24
|
177
|
78
|
37
|
|
Short-Term Investments |
0
|
40
|
48
|
48
|
19
|
|
Total Receivables |
1
|
2
|
4
|
4
|
3
|
|
Accounts Receivables |
1
|
2
|
4
|
4
|
3
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
1
|
2
|
1
|
|
Other Current Assets |
1
|
2
|
3
|
4
|
2
|
|
Total Current Assets |
17
|
67
|
233
|
136
|
62
|
|
PP&E Net |
1
|
3
|
12
|
62
|
57
|
|
PP&E Gross |
1
|
3
|
12
|
62
|
57
|
|
Accumulated Depreciation |
0
|
1
|
2
|
3
|
4
|
|
Other Long-Term Assets |
0
|
0
|
3
|
4
|
3
|
|
Total Assets |
18
N/A
|
70
+284%
|
248
+256%
|
202
-19%
|
122
-40%
|
|
Liabilities | ||||||
Accounts Payable |
2
|
2
|
3
|
2
|
1
|
|
Accrued Liabilities |
1
|
3
|
8
|
13
|
12
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
3
|
1
|
1
|
0
|
0
|
|
Total Current Liabilities |
6
|
5
|
12
|
16
|
13
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
1
|
6
|
54
|
51
|
|
Total Liabilities |
6
N/A
|
6
+11%
|
19
+195%
|
70
+275%
|
65
-7%
|
|
Equity | ||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
91
|
126
|
206
|
323
|
424
|
|
Additional Paid In Capital |
104
|
190
|
436
|
456
|
481
|
|
Other Equity |
0
|
0
|
0
|
1
|
0
|
|
Total Equity |
13
N/A
|
64
+408%
|
230
+262%
|
132
-42%
|
57
-57%
|
|
Total Liabilities & Equity |
18
N/A
|
70
+284%
|
248
+256%
|
202
-19%
|
122
-40%
|
|
Shares Outstanding | ||||||
Common Shares Outstanding |
12
|
21
|
30
|
30
|
35
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|